Cellebrite DI Ltd.
CLBT
$11.43
-$0.02-0.18%
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 436.73M | 419.17M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 436.73M | 419.17M | |
| Cost of Revenue | -- | -- | 68.24M | 66.82M | |
| Gross Profit | -- | -- | 368.50M | 352.35M | |
| SG&A Expenses | -- | -- | 199.23M | 189.93M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | 374.88M | 359.25M | |
| Operating Income | -- | -- | 61.86M | 59.93M | |
| Income Before Tax | -- | -- | -144.52M | -187.33M | |
| Income Tax Expenses | -- | -- | 6.43M | 6.91M | |
| Earnings from Continuing Operations | -- | -- | -150.95 | -194.24 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -150.95M | -194.24M | |
| EBIT | -- | -- | 61.86M | 59.93M | |
| EBITDA | -- | -- | 72.43M | 70.48M | |
| EPS Basic | -- | -- | -0.76 | -0.96 | |
| Normalized Basic EPS | -- | -- | 0.11 | -0.02 | |
| EPS Diluted | -- | -- | -0.76 | -0.96 | |
| Normalized Diluted EPS | -- | -- | 0.10 | -0.02 | |
| Average Basic Shares Outstanding | -- | -- | 919.56M | 878.15M | |
| Average Diluted Shares Outstanding | -- | -- | 954.34M | 904.31M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |